Piolax Inc. Announces Consolidated Financial Results for the Nine Moths Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015; Provides Dividend Guidance for the Year Ending March 31, 2015
February 08, 2015
Share
Piolax Inc. announced consolidated financial results for the nine moths ended December 31, 2014. For the year, the company reported net sales of ¥44,309 million against ¥40,370 million a year ago. Operating income of ¥6,350 million against ¥5,653 million a year ago. Ordinary income was ¥7,007 million against ¥6,288 million a year ago. Net income was ¥4,906 million or ¥394.44 per share against ¥4,495 million or ¥361.38 per share a year ago. Net income before taxes and other adjustments was ¥7,007 million against ¥6,622 million a year ago.
The company expects a dividend of ¥27.50 per share for the year ending March 31, 2015.
For the year ending March 31, 2015, the company expects net sales of ¥58,500 million, operating income of ¥7,800 million, ordinary income of ¥8,500 million and net income of ¥5,700 million or ¥458.25 per share.
PIOLAX, INC. is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Piolax Inc. Announces Consolidated Financial Results for the Nine Moths Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015; Provides Dividend Guidance for the Year Ending March 31, 2015
PIOLAX, INC. 
